Panigrahi: Healthcare treats human health as binary rather than a spectrum
Subhendu Panigrahi · Ep1: Living to 100: India’s Longevity Moment ft. Subhendu Panigrahi · Apr 1, 2026 · at 4:35
Subhendu Panigrahi, co-founder and CEO of longevity startup FOXO, explains the contrarian thesis behind the company's preventative healthcare approach.
0:00 / 0:14exact quote · 14.7s
▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark
“Even the way the healthcare today looks at, You know, the human body is very binary. Either you are healthy or you are diseased. The moment you are diseased, there is an ecosystem to serve you. But you are, but that's not what is happening. What is happening exactly is that you are on a spectrum.”
quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →
More from Subhendu Panigrahi
Panigrahi claims Indian clinics are curing Alzheimer's using exosome therapy.
“There are players who do stem cell rejuvenation. They are curing dementia and Alzheimer through exosome therapy or stem cell rejuvenation.”
Panigrahi predicts an incoming superbug will cause the next global pandemic.
“There's a superbug coming, right? That will be another pandemic.”
Panigrahi: AI Health Coaches Will Not Replace Humans in Healthcare
“You can't replace, take human out of the healthcare. Not gonna happen. Even if I'm building it, I'll say, always say that.”
Panigrahi: High-dose multivitamin IV therapies might not be relevant for Indians
“Some of those things might not be relevant for Indians today. Like, IV therapies might not be relevant for Indians today because their overdose of cocktail of multivitamins and minerals and you give it to them in one shot, right?”
Panigrahi: Authentic Ayurveda requires hyper-personalized, N-of-1 care
“If you really want to truly practice Ayurveda, you have to do an equal to one. And there are not enough great practitioners who do that today.”
Panigrahi: If FOXO succeeds, pharmaceutical sales should decline
“We will see less and lesser number of people going into diabetes, hypertension, or cardiac issues, which means lesser pills, right? So, the biggest change I see is that if we are, if we succeed, then the sales of pharma should be less.”